Molecular Partners develops treatment for COVID-19 | GZA

“The biotechnology firm Molecular Partners has launched a therapy program to combat COVID-19. The company has developed artificial proteins aimed at neutralizing the SARS-CoV-2 virus.”

Read the full article @ Greater Zurich Area: